GILORALIMAB
UNII W6C58X3BFH

Substance Identification & Data

This profile provides standardized clinical and technical data for Giloralimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) W6C58X3BFH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2226292-20-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

W6C58X3BFH

CAS Registry Number

2226292-20-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GILORALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C139553

National Cancer Institute reference terminology for clinical and research data.

INN ID

11241

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Giloralimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GILORALIMAB

Common Names & Synonyms

AGONISTIC ANTI-CD40 MONOCLONAL ANTIBODY ABBV-927

ANTI-CD40 AGONIST MONOCLONAL ANTIBODY ABBV-927

GILORALIMAB [INN]

GILORALIMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD40 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1614645 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1614645 .KAPPA.-CHAIN, DIMER

SYS